Through our Biotope Ventures Fund, we provide a €250k cash investment in the form of a convertible loan. It will give you the necessary runway to de-risk your early innovation and prepare your startup for seed financing.
In June, we announced the first close of Boptope Ventures II. With our first fund, we invested in 16 European startups over 3 years across food, agriculture and materials.
We secured €5 million in the first close of our second fund, marking a major step toward our €9 million target over the next 18 months. The Biotope Ventures fund will enable us to invest €250,000 in up to 30 international early-stage biotech startups.
Limited partners
Anacura is an independent laboratory group with more than 250 dynamic employees based in Evergem (Ghent) and Bruges. Active in various areas of healthcare, anacura is known for its customer-centric support. Anacura’s daughter companies AnaBioTec, Labo Nuytinck and OHMX.bio deliver end-to-end analytical drug development and omics solutions for pharma and biotech clients, as well as affordable, high-quality lab services for patients and healthcare providers.
SFPIM Relaunch is a subsidiary of the Federal Holding and Investment Company (SFPIM), Belgium’s Sovereign Wealth Fund. It supports current or future Belgian companies whose business model, in addition to a normal financial return, makes an important contribution to the transition in terms of mobility, inclusion, productivity and/or digitalisation.

“The strength of biotope lies in the combination of its high-quality biotech incubator program with a dedicated fund.”
Annick Verween
Head of biotope